Literature DB >> 33259800

A Meta-analysis of Intravenous Iron Therapy for Patients With Iron Deficiency and Heart Failure.

Mohammed Osman1, Moinuddin Syed1, Sudarshan Balla1, Babikir Kheiri2, Mohammed Faisaluddin3, Christopher Bianco4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33259800      PMCID： PMC8382095          DOI： 10.1016/j.amjcard.2020.11.025

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  5 in total

Review 1.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Monica M Colvin; Mark H Drazner; Gerasimos S Filippatos; Gregg C Fonarow; Michael M Givertz; Steven M Hollenberg; JoAnn Lindenfeld; Frederick A Masoudi; Patrick E McBride; Pamela N Peterson; Lynne Warner Stevenson; Cheryl Westlake
Journal:  J Card Fail       Date:  2017-04-28       Impact factor: 5.712

2.  Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.

Authors:  Piotr Ponikowski; Bridget-Anne Kirwan; Stefan D Anker; Theresa McDonagh; Maria Dorobantu; Jarosław Drozdz; Vincent Fabien; Gerasimos Filippatos; Udo Michael Göhring; Andre Keren; Irakli Khintibidze; Hans Kragten; Felipe A Martinez; Marco Metra; Davor Milicic; José C Nicolau; Marcus Ohlsson; Alexander Parkhomenko; Domingo A Pascual-Figal; Frank Ruschitzka; David Sim; Hadi Skouri; Peter van der Meer; Basil S Lewis; Josep Comin-Colet; Stephan von Haehling; Alain Cohen-Solal; Nicolas Danchin; Wolfram Doehner; Henry J Dargie; Michael Motro; Javed Butler; Tim Friede; Klaus H Jensen; Stuart Pocock; Ewa A Jankowska
Journal:  Lancet       Date:  2020-11-13       Impact factor: 79.321

3.  Ferric carboxymaltose in patients with heart failure and iron deficiency.

Authors:  Stefan D Anker; Josep Comin Colet; Gerasimos Filippatos; Ronnie Willenheimer; Kenneth Dickstein; Helmut Drexler; Thomas F Lüscher; Boris Bart; Waldemar Banasiak; Joanna Niegowska; Bridget-Anne Kirwan; Claudio Mori; Barbara von Eisenhart Rothe; Stuart J Pocock; Philip A Poole-Wilson; Piotr Ponikowski
Journal:  N Engl J Med       Date:  2009-11-17       Impact factor: 91.245

4.  Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency.

Authors:  Dirk J van Veldhuisen; Piotr Ponikowski; Peter van der Meer; Marco Metra; Michael Böhm; Artem Doletsky; Adriaan A Voors; Iain C Macdougall; Stefan D Anker; Bernard Roubert; Lorraine Zakin; Alain Cohen-Solal
Journal:  Circulation       Date:  2017-07-12       Impact factor: 29.690

5.  Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†.

Authors:  Piotr Ponikowski; Dirk J van Veldhuisen; Josep Comin-Colet; Georg Ertl; Michel Komajda; Viacheslav Mareev; Theresa McDonagh; Alexander Parkhomenko; Luigi Tavazzi; Victoria Levesque; Claudio Mori; Bernard Roubert; Gerasimos Filippatos; Frank Ruschitzka; Stefan D Anker
Journal:  Eur Heart J       Date:  2014-08-31       Impact factor: 29.983
  5 in total
  2 in total

Review 1.  Iron-Deficiency in Atopic Diseases: Innate Immune Priming by Allergens and Siderophores.

Authors:  Franziska Roth-Walter
Journal:  Front Allergy       Date:  2022-05-10

Review 2.  Management of Heart Failure in Patients with Chronic Kidney Disease.

Authors:  David K Ryan; Debasish Banerjee; Fadi Jouhra
Journal:  Eur Cardiol       Date:  2022-07-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.